Work

Single cell phenotyping of PDL1 and HLA1 on circulating tumor cells (CTC) in clear cell renal cell carcinoma (ccRCC) on systemic treatment with immunotherapy (IO) and vascular endothelial growth factor receptor tyrosine kinase inhibitors (TKI).

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.6_suppl.381

Authors: Hamid Emamekhoo, Matthew C Mannino, Matthew L Bootsma, Rory M. Bade, Meghan Wells, Jennifer L. Schehr, Toni K. Choueiri, Rana R. McKay, Shuang Zhao, Joshua Michael Lang

Institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, University of Wisconsin Health, Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, University of California San Diego

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W4213348668

Cites:

Cited by:

Related to: 10